Efficacy of 23-valent pneumococcal polysaccharide vaccine in nursinghome residents- A double blind, randomized and placebo controlled trial
- Conditions
- Pneumococcal pneumonia in nursinghome residents
- Registration Number
- JPRN-jRCT1090220024
- Lead Sponsor
- Mie University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1000
1.Japanese nursinghome residents
2.Signed informed consent from the patient or atorney.
3. The patient or atorney is able to comply with the study protocol for the duration of the study; available to undergo physical examinations as required by the protocol; and able to report on their health conditions such as symptoms.
1. Patients previously given pneumococcal vaccine.
2. Patients hypersensitive to vaccine components.
3. Immunocompromised people with presumed poor response to the vaccine
(such as patients with myeloma or active malignant disease, neutrophils <1.0x109/L, hypogammmaglobulinaemia, human immunodeficiency virus (HIV) infection, solid-organ or bone-marrow transplantation or those under dialysis)
4. Patients judged by the investigator to be inappropriate for inclusion for any other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method